GREAT BASIN SCIENTIFIC INC (GBSN) financial statements (2020 and earlier)

Company profile

Business Address 420 E. SOUTH TEMPLE
SALT LAKE CITY, UT 84111
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

3/31/2017
TTM
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 152
Cash and cash equivalents 152
Receivables 000
Inventory, net of allowances, customer advances and progress billings 110
Inventory 110
Deferred costs 00 
Other undisclosed current assets 48140
Total current assets: 51213
Noncurrent Assets
Property, plant and equipment 1084
Intangible assets, net (including goodwill) 001
Intangible assets, net (excluding goodwill) 001
Restricted cash and investments 12  
Other undisclosed noncurrent assets   (0)
Total noncurrent assets: 2284
TOTAL ASSETS: 73298
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 1042
Accounts payable 421
Accrued liabilities 611
Employee-related liabilities   0
Taxes payable   0
Debt 6111
Due to related parties 110
Other undisclosed current liabilities  2(0)
Total current liabilities: 7173
Noncurrent Liabilities
Long-term debt and lease obligation 1512
Long-term debt, excluding current maturities 1510
Capital lease obligations 012
Liabilities, other than long-term debt 434310
Financial instruments subject to mandatory redemption, settlement terms, share value, amount 6  
Other liabilities 1  
Derivative instruments and hedges, liabilities 364310
Total noncurrent liabilities: 584512
Total liabilities: 1295216
Stockholders' equity
Stockholders' equity attributable to parent (56)(23)(8)
Preferred stock 00 
Common stock 000
Additional paid in capital 1559956
Accumulated deficit (211)(122)(64)
Total stockholders' equity: (56)(23)(8)
TOTAL LIABILITIES AND EQUITY: 73298

Income statement (P&L) ($ in millions)

3/31/2017
TTM
12/31/2016
12/31/2015
12/31/2014
Revenues 322
Cost of revenue (8)(5)(4)
Gross profit: (5)(3)(2)
Operating expenses (29)(20)(10)
Operating loss: (34)(22)(12)
Nonoperating expense (55)(35)(10)
Interest and debt expense (24)(12)(1)
Other undisclosed income from continuing operations before equity method investments, income taxes 24121
Loss from continuing operations before income taxes: (89)(58)(22)
Income tax expense (0)(0)(0)
Net loss available to common stockholders, diluted: (89)(58)(22)

Comprehensive Income ($ in millions)

3/31/2017
TTM
12/31/2016
12/31/2015
12/31/2014
Net loss: (89)(58)(22)
Comprehensive loss, net of tax, attributable to parent: (89)(58)(22)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: